AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024
AbCellera (Nasdaq: ABCL) will unveil its second quarter 2024 financial results on August 6, 2024. The company has scheduled an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day. Interested parties can access the live audio webcast via a link on AbCellera's Investor Relations website, where a replay will also be available post-conference.
- None.
- None.
A live audio webcast of the earnings conference may be accessed through a link that will be posted on AbCellera’s Investor Relations website. A replay will be available through the same link following the conference call.
About AbCellera Biologics Inc.
AbCellera (Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners. For more information, please visit www.abcellera.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240625594162/en/
Inquiries
Media: Kathleen Reid; media@abcellera.com, +1(236)521-6774
Business Development: Murray McCutcheon, Ph.D.; bd@abcellera.com, +1(604)559-9005
Investor Relations: Melanie Solomon; ir@abcellera.com, +1(778)729-9116
Source: AbCellera Biologics Inc.
FAQ
When will AbCellera report its Q2 2024 financial results?
At what time is AbCellera's second quarter 2024 earnings conference call?
How can I access the AbCellera Q2 2024 earnings call webcast?